Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001583648-18-000022
Filing Date
2018-04-26
Accepted
2018-04-26 06:19:37
Documents
5
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A pirs-10xk_a.htm 10-K/A 210495
2 EXHIBIT 10.15 pirs-serviercollaborationa.htm EX-10.15 1099805
3 EXHIBIT 10.16 pirs-servierplatformagreem.htm EX-10.16 201908
4 EXHIBIT 31.1 a180423syo10kacert.htm EX-31.1 2613
5 EXHIBIT 31.2 a180423are10kacert.htm EX-31.2 2859
  Complete submission text file 0001583648-18-000022.txt   1518808
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37471 | Film No.: 18775981
SIC: 8731 Services-Commercial Physical & Biological Research